Brief: Akums Drugs And Pharmaceuticals Enters Into Exclusive Master Sales Agreement With Caregen Co
19/11/2024 07:34
Nov 19 (Reuters) - Caregen Co Ltd 214370.KQ :
* AKUMS DRUGS AND PHARMACEUTICALS - ENTERED INTO EXCLUSIVE
MASTER
SALES AGREEMENT WITH CAREGEN CO
* AKUMS DRUGS AND PHARMACEUTICALS - GRANTED EXCLUSIVE RIGHTS
TO
SELL CERTAIN CAREGEN PRODUCTS IN INDIA
Source text: ID:nBSE2tp8d
Further company coverage: 214370.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caregen
See all newsBrief: Caregen Q2 Operating Profit 7.4 Billion Won, Up 20.4% From Year Earlier
Brief: Caregen Q1 Operating Profit 10.2 Billion Won, Up 10% From Year Earlier
Brief: Caregen Q4 Operating Profit 8.2 Billion Won, Down 21% From Year Earlier
Brief: Akums Drugs And Pharmaceuticals Enters Into Exclusive Master Sales Agreement With Caregen Co
India's Akum Drugs rises on agreement with South Korean co